No attachments available.
Transplant Coordinator Support for Clinical Center
Contact and place of performance
Elaine Estrella
Bethesda, MD 20892
USA
NON-COMPETITIVE COMBINED SYNOPSIS / SOLICITATION Title: Transplant Coordinator Support for Clinical Center (i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitatio...
View more(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01 dated January 01, 2026
(iv) The associated NAICS code is 541690 , and the small business size standard is $19 million. This requirement is set aside for small business.
(v) Description of Requirement: The clinical research focus of the Genetic Immunotherapy Section (GIS) of the Laboratory of Clinical Immunology and Microbiology (LCIM), Division of Intramural Research (DIR), National Institute of Allergy and Infectious Diseases (NIAID) is to develop potentially curative cellular therapies for Inborn Errors of Immunity (IEI) that includes the conduct of clinical research protocols for allogeneic donor hematopoietic stem cell transplants and gene therapy conducted at the NIH Clinical Center (CC). The development of potentially curative treatments for inherited disorders including Inborn Errors of Immunity (IEI) is a core mission of the NIAID and the NIH. The conduct of clinical trials of allogeneic transplant and gene therapy requires the support services of an experienced Transplant Coordinator registered with and authorized by the National Marrow Donor Program (NMDP) to conduct searches in the national and international donor registries to determine if patients participating in NIH transplant and gene therapy protocols have a matched donor. The expert transplant coordinator also arranges for any final donor choice for collection of a hematopoietic stem cell donor product, the receipt of that donor product at the NIH CC and scheduling the day of transplantation of the donor product to the NIH CC inpatient in need of a donor graft. These services are essential to ensure timely donor identification, graft procurement, and compliance with NIH Institutional Review Board (IRB) approved NIAID therapeutic clinical protocols 000977-I, 001562-I, 000186-I, 002273-I, 11-I-0007 and 002199-I.
(vi) Delivery Location: NIH / NIAID 10 Center Drive BLDG 10CRC RM 5-3750 Bethesda, MD 20892
(vii) [Reserved, if needed]
(viii) The provision at FAR 52.212-1, Instructions to Offerors—Commercial Items, applies to this acquisition. Add any additional instructions as required.
(ix) The provision at FAR 52.212-2, Evaluation—Commercial Items, applies to this acquisition.
(a) A written notice of award or acceptance of an offer, issued to the successful offeror within the time specified in the offer, shall result in a binding contract without further action by either party. The Government reserves the right to accept any offer (or part of an offer) before the expiration date, whether or not discussions are conducted, unless a written notice of withdrawal is received prior to award. Add additional evaluation criteria as required.
(x) Offerors shall include a completed copy of FAR 52.212-3, Offeror Representations and Certifications—Commercial Items, with their offer.
(xi) FAR 52.212-4, Contract Terms and Conditions—Commercial Items, applies to this acquisition.
(xii) FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders—Commercial Items, applies to this acquisition.
(xiii) Additional contract requirements or terms and conditions, as determined necessary by the Contracting Officer and consistent with customary commercial practices: None.
(xiv) The Defense Priorities and Allocations System (DPAS) is not applicable to this requirement.
(xv) Submission Requirements: Responses must include sufficient information to demonstrate the respondent’s capability to provide the required product or service. Price quotations shall include, at a minimum: unit price, list price, shipping and handling costs, delivery timeframe after award, delivery terms, prompt payment discount terms, F.O.B. point (destination or origin), product or catalog numbers, product descriptions, and any other relevant information.
Evaluation factors may include, but are not limited to: past performance, technical capability, special features, trade-in considerations, expected lifecycle, warranty, maintenance availability, and environmental or energy efficiency considerations.
Respondents claiming to be manufacturers or authorized resellers of a specified brand-name product must provide: (a) Product, catalog, model, and/or part number(s); (b) Product description; (c) Documentation demonstrating that the offered item meets all required salient characteristics; (d) Quantity; (e) Estimated price or cost; (f) Shipping, handling, and/or installation charges; and (g) Delivery timeframe after receipt of order.
Responses must also include the Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification. All offerors must be actively registered in the System for Award Management (SAM) at www.sam.gov.
All responses must be received by June 15, 2026 at 5pm Eastern Standard Time (EST) and must reference solicitation number 75N98026Q00515. Responses may be submitted electronically to [email protected] and [email protected]. Faxed proposal or mailed proposal will not be accepted.
(xvi) Point of Contact: Elaine Estrella, Contract Specialist, [email protected] and Brian Lind, Contract Specialist. [email protected]
The National Institutes of Health, Office of the Director, Office of Acquisitions, intends to negotiate a non-competitive firm-fixed-price purchase order with Hilligoss Healthcare Consulting, LLC for transplant coordinator support services. This requirement supports the Genetic Immunotherapy Section of the National Institute of Allergy and Infectious Diseases (NIAID) in developing cellular therapies for Inborn Errors of Immunity at the NIH Clinical Center in Bethesda, Maryland. The contractor will provide specialty clinical expertise to identify compatible bone marrow donors through the National Marrow Donor Program and collate clinical data for six specific NIAID therapeutic clinical protocols. These services include arranging the collection of hematopoietic stem cell donor products, managing the receipt of those products, and scheduling transplantations to ensure compliance with Institutional Review Board requirements and federal clinical trial regulations.
This acquisition is classified under NAICS 541690 Other Scientific and Technical Consulting Services and PSC R499 SUPPORT- PROFESSIONAL: OTHER. The notice is issued as a combined synopsis/solicitation and is designated as an SBA Small Business Administration set-aside. Although the government intends to award this requirement on a non-competitive basis, responses must include sufficient information to demonstrate the respondent’s capability to provide the required services. All submissions must reference solicitation number 75N98026Q00515 and be received electronically by Elaine Estrella no later than June 15, 2026, at 5:00 PM EST.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.